Background: We wished to investigate potential causes of dialysis-induced hypotension (DIH), including the attenuated cardiovascular response to sympathetic system activation during exercise and myocardial dysfunction. Methods: This study included 26 end-stage renal disease (ESRD) patients with DIH, 30 ESRD patients without DIH (Non-DIH), and 30 control subjects. Each patient was evaluated with echocardiography and a symptom-limited treadmill stress test. The chronotropic index (CRI), heart rate recovery (HRR), systolic blood pressure response to exercise (SBP response), and tissue Doppler systolic myocardial velocities were calculated. Results: The HRR and velocities were reduced in dialysis patients compared to controls; however, they were similar in patients with and without DIH. Patients with DIH had the lowest CRI compared to theNon-DIH group (0.62 ± 0.15 vs. 0.73 ± 0.17, p = 0.020) and controls (0.62 ± 0.15 vs. 0.86 ± 0.11, p < 0.001). Similarly, patients with DIH had the lowest SBP response values compared to the Non-DIH (34.88 ± 15.01 vs. 55.67 ± 25.42, p = 0.002) and controls (34.88 ± 15.01 vs. 59.70 ± 23.04, p < 0.001). Conclusion: Patients with DIH have inadequate sympathetic activity of the cardiovascular system during exercise and impaired left ventricular systolic function. Both factors could contribute to the development of hypotension during hemodialysis.

1.
Henrich WL: Hemodynamic instability during hemodialysis. Kidney Int 1986;30:605–612.
2.
Maher JF, Schreiner GE: Hazards and complications of dialysis. N Engl J Med 1965;273:370–377.
3.
Daugirdas JT: Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001;38(suppl 4):S11–S17.
4.
Andrulli S, Colzani S, Mascia F, et al: The role of blood volume reduction in the genesis of intradialytic hypotension. Am J Kidney Dis 2002;40:1244–1254.
5.
Lazarus JM, Henderson LW, Kjellstrand CM, et al: Cardiovascular instability during dialysis. Trans Am Soc Artif Intern Organs 1982;28:656–665.
6.
Davis CL, Henrich WL: Cardiac performance in chronic renal failure. Int J Artif Organs 1985;8:7–10.
7.
Campese VM, Romoff MS, Levitan D, et al: Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981;20:246–253.
8.
Stojeva-Taneva O, Masin G, Polenakovic M, et al: Autonomic nervous system dysfunction and volume nonresponsive hypotension in hemodialysis patients. Am J Nephrol 1991;11:123–126.
9.
Daul AE, Wang XL, Brodde OE: Arterial hypotension in chronic hemodialyzed patients. Kidney Int 1987;32:728–735.
10.
Zoccali C, Ciccarelli M, Mallamaci F, et al: Parasympathetic function in haemodialysis patients. Nephron 1986;44:351–354.
11.
World Health Organization: Diabetes Mellitus: A Report of a WHO Study Group (WHO publication No. 727). Geneva, World Health Organization, 1985.
12.
Sato M, Horigome I, Chiba S, et al: Autonomic insufficiency as a factor contributing to dialysis-induced hypotension. Nephrol Dial Transplant 2001;16:1657–1662.
13.
Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27–39.
14.
Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of the left ventricular hypertrophy: comparison necropsy findings. Am J Cardiol 1986;57:450–458.
15.
Doan AE, Peterson DR, Blackmon JR, et al: Myocardial ischemia after maximal exercise in healthy men. Am Heart J 1965;69:11–21.
16.
Fletcher GF, Froelicher VF, Hartley LH, et al: Exercise standards: a statement for health professionals from the American Heart Association. Circulation 1990;82:2286–2322.
17.
Nishime EO, Cole CR, Blackstone EH, et al: Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000;284:1392–1398.
18.
Lauer MS, Francis GS, Okin PM, et al: Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999;281:524–529.
19.
Amon KW, Richards KL, Crawford MH: Usefullness of the postexercise response of systolic blood pressure in the diagnosis of coronary artery disease. Circulation 1984;70:951–956.
20.
Ponikowski PP, Chua TP, Francis DP, et al: Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 2001;104:2324–2330.
21.
Christensen NJ, Galbo H: Sympathetic nervous activity during exercise. Ann Rev Physiol 1983;45:139–153.
22.
Miyahara T, Yokota M, Iwase M, et al: Mechanism of abnormal postexercise systolic blood pressure response and its diagnostic value in patients with coronary artery disease. Am Heart J 1990;120:40–49.
23.
Iellamo F, Pizzinelli P, Massaro M, et al: Muscle metaboreflex contribution to sinus node regulation during static exercise: insights from spectral analysis of heart rate variability. Circulation 1999;100:27–32.
24.
Converse RL Jr, Jacobsen TN, Jost CM, et al: Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 1992;90:1657–1665.
25.
Landry DW, Oliver JA: Blood pressure instability during hemodialysis. Kidney Int 2006;69:1710–1711.
26.
Moore TJ, Lazarus JM, Hakim RM: Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. Kidney Int 1989;36:696–701.
27.
Coll E, Larrousse M, de la Sierra A, et al: Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents. Clin Nephrol 2008;69:114–120.
28.
Cole CR, Blackstone EH, Pashkow FJ, et al: Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341:1351–1357.
29.
Imai K, Sato H, Hori M, et al: Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 1994;24:1529–1535.
30.
Hull SS Jr, Vanoli E, Adamson PB, et al: Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995;91:2516–2519.
31.
Singh JP, Larson MG, Manolio TA, et al: Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham Heart Study. Circulation 1999;99:1831–1836.
32.
Lim PO, MacFadyen RJ, Clarkson PB, et al: Impaired exercise tolerance in hypertensive patients. Ann Intern Med 1996;124:41–55.
33.
Morrow K, Morris CK, Froelicher VF, et al: Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med 1993;118:689–695.
34.
Kodama S, Saito K, Tanaka S, et al: Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009;301:2024–2035.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.